Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders

By Basquiera Ana L.   Soria Néstor W.   Ryser Ricardo   Salguero Miriam   Moiraghi Beatriz   Sackmann Federico   Sturich Ana G.   Borello Adriana   Berretta Adriana   Bonafé Miriam   Barral José Moreno   Palazzo Emilio D.   García Juan J.  

Hematology, Vol. 14, Iss. 6, 2009-12 ,pp. : 323-330

Maney Publishing

Access to resources Recommend Favorite

Diagnostic refinement of chronic myeloproliferative disorders and thrombocytoses of unknown origin by multiple RT-PCR and capillary electrophoresis of BCR-ABL rearrangements and JAK2 (V617F) mutation

By Ammatuna Emanuele   Ottone Tiziana   Zaza Serena   Lavorgna Serena   Grillo Rosa   Curzi Paola   Panetta Paola   Federici Giorgio   Amadori Sergio   Lo-Coco Francesco  

Annals of Hematology, Vol. 86, Iss. 5, 2007-05 ,pp. : 355-361

Springer Publishing Company

Access to resources Recommend Favorite

Real‐Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2V617F mutation in Philadelphia‐negative chronic myeloproliferative neoplasms

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 6, 2015-12 ,pp. : 766-773

John Wiley & Sons Inc

Access to resources Recommend Favorite

JAK2 46/1 haplotype is associated with JAK2 V617F – positive myeloproliferative neoplasms in Brazilian patients

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 5, 2015-10 ,pp. : 654-660

John Wiley & Sons Inc

Access to resources Recommend Favorite

The implication of identifying JAK2 V617F in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis

By Olsen Randall  

Journal of Hematopathology, Vol. 1, Iss. 2, 2008-09 ,pp. : 111-117

Springer Publishing Company

Access to resources Recommend Favorite